Literature DB >> 8374937

Assessment of health-related quality of life in migraine.

C Dahlöf.   

Abstract

Assessment of HQL has become an important complement to the traditional methods that are used for objective registration of physiological, structural or biochemical processes during an illness. A generally applicable definition of HQL includes both subjective perception of one's life situation and objectively registrable health factors. This manner of evaluating quality of life perhaps will achieve further acceptance and thereby facilitate both reporting and evaluation of quality-of-life measurements. To document changes in HQL more precisely, reliable and valid test instruments with sufficient sensitivity to detect clinically relevant changes are essential. Available data indicate that the individual's personality, the migraine attack or its treatment or both can influence the patient's HQL. At present it is unclear which of the available acute treatments for migraine attacks produces the best general well-being or highest quality of life. It is probable that, as in other therapeutic areas, an optimal treatment result can only be achieved with an individualized therapeutic strategy.

Entities:  

Mesh:

Year:  1993        PMID: 8374937     DOI: 10.1046/j.1468-2982.1993.1304233.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

1.  A multinational investigation of the impact of subcutaneous sumatriptan. III: Workplace productivity and non-workplace activity.

Authors:  P Cortelli; C Dahlöf; J Bouchard; J Heywood; J P Jansen; S Pham; J Hirsch; J Adams; D W Miller
Journal:  Pharmacoeconomics       Date:  1997       Impact factor: 4.981

2.  A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life.

Authors:  C Dahlöf; J Bouchard; P Cortelli; J Heywood; J P Jansen; S Pham; J Hirsch; J Adams; D W Miller
Journal:  Pharmacoeconomics       Date:  1997       Impact factor: 4.981

3.  Perceptions and needs of patients with migraine: a focus group study.

Authors:  Constance K Cottrell; Jana B Drew; Sharon E Waller; Kenneth A Holroyd; John A Brose; Francis J O'Donnell
Journal:  J Fam Pract       Date:  2002-02       Impact factor: 0.493

4.  The responsiveness of headache impact scales scored using 'classical' and 'modern' psychometric methods: a re-analysis of three clinical trials.

Authors:  M Kosinski; J B Bjorner; J E Ware; A Batenhorst; R K Cady
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

5.  The three dimensions of headache impact: pain, disability and affective distress.

Authors:  Kenneth A Holroyd; Peter Malinoski; Katherine M Davis; Gay L Lipchik
Journal:  Pain       Date:  1999-12       Impact factor: 7.926

6.  Comparison of validity and reliability of the Migraine disability assessment (MIDAS) versus headache impact test (HIT) in an Iranian population.

Authors:  Abbas Ghorbani; Ahmad Chitsaz
Journal:  Iran J Neurol       Date:  2011

7.  Bilateral stellate ganglion block for migraine: A case report.

Authors:  Suyoung Moon; Joonhee Lee; Younghoon Jeon
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.